X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2233) 2233
Book Review (188) 188
Newsletter (102) 102
Publication (95) 95
Book Chapter (11) 11
Magazine Article (11) 11
Book / eBook (4) 4
Reference (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1781) 1781
disulfiram - pharmacology (1301) 1301
animals (1231) 1231
disulfiram (985) 985
humans (873) 873
male (843) 843
rats (735) 735
pharmacology & pharmacy (467) 467
female (384) 384
mice (299) 299
disulfiram - therapeutic use (215) 215
alcoholism (199) 199
adult (195) 195
aldehyde dehydrogenase (195) 195
drug interactions (195) 195
alcoholism - drug therapy (172) 172
toxicology (167) 167
ethanol - pharmacology (166) 166
inhibition (162) 162
kinetics (161) 161
rats, inbred strains (154) 154
aldehyde dehydrogenase - antagonists & inhibitors (150) 150
ditiocarb - pharmacology (150) 150
dose-response relationship, drug (149) 149
liver - enzymology (149) 149
biochemistry & molecular biology (147) 147
enzyme inhibitors - pharmacology (145) 145
research (139) 139
time factors (139) 139
disulfiram - administration & dosage (135) 135
in vitro techniques (130) 130
ethanol (128) 128
old medline (126) 126
middle aged (123) 123
psychiatry (117) 117
metabolism (116) 116
substance abuse (116) 116
acetaldehyde (107) 107
liver - drug effects (107) 107
cancer (105) 105
care and treatment (105) 105
liver - metabolism (104) 104
naltrexone (103) 103
alcohol deterrents - therapeutic use (102) 102
cell line, tumor (98) 98
alcohol (96) 96
aldehyde dehydrogenase - metabolism (96) 96
rats, sprague-dawley (92) 92
disulfiram - metabolism (90) 90
drug synergism (90) 90
ethanol - metabolism (90) 90
brain - metabolism (89) 89
alcohol deterrents - pharmacology (88) 88
diethyldithiocarbamate (88) 88
disulfiram - adverse effects (88) 88
drug therapy (88) 88
neurosciences (87) 87
abridged index medicus (86) 86
apoptosis (83) 83
analysis (82) 82
thiocarbamates - pharmacology (82) 82
pharmacology (79) 79
acetaldehyde - blood (75) 75
brain - drug effects (75) 75
rabbits (75) 75
oxidation-reduction (74) 74
rat (72) 72
copper (70) 70
in-vitro (70) 70
oncology (70) 70
acamprosate (69) 69
acetaldehyde - metabolism (68) 68
pharmacotherapy (68) 68
norepinephrine - metabolism (67) 67
oxidative stress (67) 67
dopamine - metabolism (66) 66
liver (66) 66
antineoplastic agents - pharmacology (64) 64
article (64) 64
drugs (61) 61
chromatography, high pressure liquid (60) 60
cocaine (59) 59
dopamine (59) 59
alcohol dependence (58) 58
reserpine - pharmacology (58) 58
dopamine beta-hydroxylase - antagonists & inhibitors (57) 57
drug abuse (57) 57
apoptosis - drug effects (56) 56
enzymes (56) 56
placebo-controlled trial (56) 56
alcohol use (55) 55
toxicity (55) 55
administration, oral (54) 54
health aspects (54) 54
reports (54) 54
aldehyde oxidoreductases - antagonists & inhibitors (53) 53
brain (53) 53
depression, chemical (53) 53
cell biology (52) 52
chemistry, medicinal (52) 52
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2166) 2166
Russian (50) 50
French (49) 49
German (47) 47
Japanese (16) 16
Italian (6) 6
Polish (5) 5
Spanish (4) 4
Czech (2) 2
Dutch (2) 2
Hungarian (2) 2
Norwegian (2) 2
Bulgarian (1) 1
Chinese (1) 1
Danish (1) 1
Finnish (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 4, pp. 425 - 429
Journal Article
Addiction Biology, ISSN 1355-6215, 03/2017, Volume 22, Issue 2, pp. 291 - 302
Although dysregulation of the dopaminergic mesolimbic system is generally considered central to addiction, the involvement of other circuits is increasingly... 
ethanol reinforcement | Adrenergic receptors | posterior ventral tegmental area | dopamine D | receptors | locus coeruleus | α | WISTAR RATS | alpha-Adrenergic receptors | NOREPINEPHRINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | SUBSTANCE ABUSE | MESOLIMBIC DOPAMINE SYSTEM | PREFRONTAL CORTEX | MICE LACKING | NUCLEUS-ACCUMBENS | dopamine D-1 receptors | NEURONS | AMPHETAMINE | BRAIN | PARKINSONS-DISEASE | Lidocaine - pharmacology | Muscimol - pharmacology | Tyrosine 3-Monooxygenase - metabolism | Rats, Wistar | Locus Coeruleus - drug effects | Ethanol - administration & dosage | Male | Anesthetics, Local - pharmacology | Adrenergic alpha-1 Receptor Agonists - pharmacology | Central Nervous System Depressants - pharmacology | Self Administration | Phenylephrine - pharmacology | Adrenergic alpha-1 Receptor Antagonists - pharmacology | GABA-A Receptor Agonists - pharmacology | Prazosin - pharmacology | Behavior, Animal - drug effects | Adrenergic Neurons - drug effects | Receptors, Dopamine D1 - antagonists & inhibitors | Ventral Tegmental Area - drug effects | Reinforcement (Psychology) | Rats | Benzazepines - pharmacology | Tyrosine 3-Monooxygenase - drug effects | Adrenergic Agents - pharmacology | Ethanol - pharmacology | Animals | Dopamine Antagonists - pharmacology | Ventral Tegmental Area - metabolism | Central Nervous System Depressants - administration & dosage | Acetaldehyde Dehydrogenase Inhibitors - pharmacology | Conditioning, Operant | Reward | Benzylamines - pharmacology | Disulfiram - pharmacology | Locus Coeruleus - metabolism | Tyrosine | Alcohol | Alcohol, Denatured | Digital signal processors | Drug addiction | Ethanol | Rodents | Addictive behaviors | Ventral tegmentum | Operant conditioning | Neurons | Mesolimbic system | Hydroxylase | Muscimol | Tyrosine 3-monooxygenase | Prazosin | Dopamine D1 receptors | Addiction | Phenylephrine | Disulfiram | Reinforcement | Norepinephrine | Degeneration | Immunoreactivity | Lidocaine | Dopamine D2 receptors | Locus coeruleus | Dopamine receptors | Index Medicus
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2015, Volume 125, Issue 5, pp. 1901 - 1912
Reversal of HIV-1 latency by small molecules is a potential cure strategy. This approach will likely require effective drug combinations to achieve high levels... 
SUPPRESSIVE ANTIRETROVIRAL THERAPY | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS REACTIVATION | ACTIVATION | RESERVOIR | IN-VIVO | GENE-EXPRESSION | CD4(+) T-CELLS | HISTONE DEACETYLASE INHIBITORS | NF-KAPPA-B | LIFELONG PERSISTENCE | Anti-HIV Agents - pharmacology | Transcription, Genetic - drug effects | Lymphokines - secretion | Humans | Middle Aged | RNA, Messenger - analysis | Male | Virus Latency - drug effects | Anti-HIV Agents - administration & dosage | HIV-1 - physiology | Phorbol Esters - pharmacology | Adult | Anti-HIV Agents - therapeutic use | Female | CD4-Positive T-Lymphocytes - virology | Drug Evaluation, Preclinical | Bryostatins - pharmacology | HIV-1 - drug effects | Lymphocyte Activation | HIV Infections - virology | Protein Kinase C - drug effects | Cells, Cultured | RNA, Viral - analysis | Virion - metabolism | Azepines - pharmacology | Drug Synergism | Triazoles - pharmacology | CD4-Positive T-Lymphocytes - secretion | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Disulfiram - pharmacology | CD4-Positive T-Lymphocytes - drug effects | Physiological aspects | Research | RNA | T cells | Drug therapy | HIV infection | Studies | Statistical analysis | Cytokines | Acquired immune deficiency syndrome--AIDS | Lymphocytes | T cell receptors | Mathematical models | Gene expression | Index Medicus | Abridged Index Medicus | HIV | Infectious disease | AIDS
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 6/2019, Volume 145, Issue 6, pp. 1495 - 1507
Constructed from a theoretical framework, the coordinated undermining of survival paths in glioblastoma (GBM) is a combination of nine drugs approved for... 
CUSP9 | Medicine & Public Health | Hematology | Glioblastoma | Repurposed drugs | Oncology | Cancer Research | Internal Medicine | Glioblastoma stem cells | Temozolomide | TARGETED THERAPY | INITIATING CELLS | INTRATUMORAL HETEROGENEITY | PHARMACODYNAMICS | CLINICAL PHARMACOKINETICS | ADJUVANT TEMOZOLOMIDE | MALIGNANT GLIOMA | DISULFIRAM | IN-VITRO | ONCOLOGY | ADULT HUMAN BRAIN | Celecoxib - administration & dosage | Captopril - pharmacology | Aprepitant - administration & dosage | Minocycline - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Brain Neoplasms - pathology | Temozolomide - pharmacology | Brain Neoplasms - metabolism | Itraconazole - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Auranofin - administration & dosage | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Glioblastoma - metabolism | Itraconazole - administration & dosage | Minocycline - administration & dosage | Tumor Cells, Cultured | Quetiapine Fumarate - pharmacology | Aprepitant - pharmacology | Auranofin - pharmacology | Reproducibility of Results | Sertraline - pharmacology | Celecoxib - pharmacology | Brain Neoplasms - drug therapy | Mice, SCID | Xenograft Model Antitumor Assays | Captopril - administration & dosage | Quetiapine Fumarate - administration & dosage | Animals | Sertraline - administration & dosage | Signal Transduction - drug effects | Temozolomide - administration & dosage | Glioblastoma - pathology | Mice | Glioblastoma - drug therapy | Disulfiram - pharmacology | Disulfiram - administration & dosage | Drug Screening Assays, Antitumor | Original – Cancer Research
Journal Article
Journal of NeuroVirology, ISSN 1355-0284, 8/2016, Volume 22, Issue 4, pp. 455 - 463
Journal Article
Journal Article
Neuroendocrinology Letters, ISSN 0172-780X, 2012, Volume 33, Issue 3, pp. 33 - 40
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 11/2010, Volume 35, Issue 12, pp. 2440 - 2449
Journal Article